ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Account Payables

Amounts the company owes suppliers for goods and services received.

No reported Account Payables figures are available to summarize.

Account Payables history

Currency unavailable · from the balance sheet

No Account Payables data reported for this period type.

Account Payables vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Account Payables for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
WVEWave Life Sciences Ltd.Mar 2026$19.06M USD+32.8%-2.5%3.3%
MGTXMeiraGTx Holdings plcMar 2026$16.66M USD-17.9%-15.4%6.8%
PRMEPrime Medicine, Inc.Mar 2026$12.33M USD+22.9%+27.1%4.2%
SLNSilence Therapeutics plcMar 2026$10.37M USD-44.9%+11.4%9.0%
STOKStoke Therapeutics, Inc.Mar 2026$6.84M USD+212.9%+86.1%1.5%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$4.09M USD-33.8%-17.2%1.7%
RNAAtrium Therapeutics, Inc.Mar 2026$807K USD——0.3%
BNTCBenitec Biopharma Inc.Mar 2026$635K USD+46.7%-21.9%0.3%
PRQRProQR Therapeutics N.V.Mar 2026€189.2K EUR-57.7%-8.7%0.2%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+2.5%-5.6%1.7%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.